Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798289 · ClinicalTrials.gov registry record · NA
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
A NA study of Dry Eye Syndrome and Keratoconjunctivitis Sicca, sponsored by Oculeve.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 2
- Study locations
NCT02798289 is a NA study of Dry Eye Syndrome and Keratoconjunctivitis Sicca that has completed, run by Oculeve. The registered enrollment target is 55 participants, below the 159-participant average among 10 other Dry Eye Syndrome trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02798289, a NA study of Dry Eye Syndrome and Keratoconjunctivitis Sicca, has completed, sponsored by Oculeve.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to evaluate acute tear production as measured by tear meniscus height (TMH) captured by optical coherence tomography (OCT) after single use of the Oculeve Intranasal Neurostimulator (OIN) in participants with dry eye.
Conditions Studied
Interventions
- DEVICE Oculeve Intranasal Neurostimulator
Study Locations (2)
California
- Sall Research Medical Center - Artesia
- Aesthetic Eyecare Institute - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02798289
The ClinicalTrials.gov registry entry for NCT02798289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 159-participant average among 10 other Dry Eye Syndrome trials with a reported enrollment target (65% lower). The listed sponsor is Oculeve, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dry Eye Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Oculeve Intranasal Neurostimulator is the first listed.
NCT02798289 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02798289 about?
NCT02798289 is a clinical study titled "Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator". The primary objective of this study is to evaluate acute tear production as measured by tear meniscus height (TMH) captured by optical coherence tomography (OCT) after single use of the Oculeve Intranasal Neurostimulator (OIN) in participants with dry eye.
What is the current status of trial NCT02798289?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2016-06. Estimated completion is 2016-08.
What conditions does trial NCT02798289 study?
This clinical trial studies the following conditions: Dry Eye Syndrome, Keratoconjunctivitis Sicca.
What interventions are being tested in trial NCT02798289?
The interventions under investigation include: Oculeve Intranasal Neurostimulator (DEVICE).
Who is sponsoring clinical trial NCT02798289?
This trial is sponsored by Oculeve, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02798289 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
COMPLETED · NA
-
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
COMPLETED · NA
-
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)
RECRUITING · Phase 1
-
Study of SkQ1 as Treatment for Dry-eye Syndrome
COMPLETED · Phase 3
-
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
COMPLETED · Phase 2
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.